Sankalp’s SAFE BLOOD Program - Information for Blood Donors
A leap forward in blood safety for potential transplant patients
A leap forward in blood safety for potential transplant patients
Prolonged blood transfusion therapy and anemia can cause cardiac problems. Cardiac problems contribute significantly to mortality and poor quality of life for thalassemia patients.
Last month we had 205 patient visits with 276 transfusions at Indira Gandhi Institute of Child Health. The average pre-transfusion hemoglobin was 8.3gm/dl and the estimated post transfusion hemoglobin was 12.1 gm/dl. At Samraksha we had 164 patient visits with 205 transfusions.
On 19th February 2015 a group of people with very high interest in improving care and management for thalassemia came together in a room to explore the next steps for thalassemia management.
The intention was to share and to learn in an environment which maximizes learning and fosters cooperation.
BANGALORE: At 13, he is suffering from a disease that requires him to get blood transfusions regularly. Thalassaemia may not be rare, but Kiran Manjappa's blood group is.
With the onset of the new financial year, Sankalp Rakta Kranti Team looked to make a strong start with plenty of blood drives catering to the summer period. On the back of a year with close to 12,000 units collection having gone by, the team wanted to maintain the same momentum. In summary, 1055 units were collected in 13 drives.
Thalassemia management offers a unique opportunity for measuring the quality of blood transfusion services. Children suffering from thalassemia who are on chronic transfusion therapy generally come back to the same centre for treatment and management. This enable insights into blood transfusion medicine which otherwise may be very difficult to get.
The book of Thalassemia International Federation’s guidelines on the management of transfusion dependant thalassemia is an essential resource for anyone involved in care giving for patients suffering from thalassemia.